Hypothesis

Age-related degeneration of white matter tracts linking the amygdala to ventral prefrontal cortex reduces excitatory drive onto BNST CRF neurons, triggering a homeostatic increase in GABAergic inhibition that lowers their excitability and consequently diminishes trait anxiety.

Mechanistic Basis

Structural decline in amygdala‑vPFC pathways correlates with lower anxiety in older adults [PMC4087066], suggesting that weakened top‑down signaling may not simply reflect loss of control but an adaptive uncoupling of threat‑sustaining circuits. Simultaneously, BNST CRF neurons act as a fast‑track for fear extinction, where their activity is bidirectionally modulated by 5‑HT2C receptors and GABA(A)α1‑mediated inhibition [PMC12873198][neurosciencenews.com/unlearning-fear-crf-bnst-30196/][doi.org/10.1073/pnas.1119261109]. We propose that the age‑related drop in glutamatergic afferents from prefrontal and amygdalar regions lessens excitatory tone on BNST CRF cells. To maintain network stability, these neurons upregulate GABA(A)α1 receptor expression or enhance ambient GABA release, thereby increasing inhibitory conductance. This compensatory GABAergic boost counteracts the intrinsic hyperexcitability seen after stress or early‑life pain [Frontiersin fnbeh.2025.1653346][doi.org/10.1126/sciadv.adk7636], leading to a net reduction in CRF release and anxiety‑like behavior.

Testable Predictions

1. Older mice will show decreased vGluT1‑positive axon density in BNST‑projecting amygdala and prefrontal fibers compared with young adults.
2. BNST CRF neurons from aged animals will exhibit higher mIPSC frequency and amplitude, reflecting enhanced GABAergic tone.
3. Chemogenetic reduction of GABA(A)α1 signaling in BNST CRF neurons of aged mice will restore CRF neuron excitability and reinstate heightened anxiety measures.
4. Pharmacological blockade of 5‑HT2C receptors will have a smaller effect on anxiety in aged versus young animals, reflecting the shifted balance toward GABA control.

Experimental Approach

• Use diffusion tensor imaging and immunohistochemistry to quantify white matter integrity and vGluT1 labeling in amygdala‑vPFC‑BNST pathways across age groups (3, 12, 24 months).
• Perform whole‑cell patch‑clamp recordings from genetically labeled BNST CRF neurons in slices, measuring mIPSC properties and excitability before and after GABA(A)α1 antagonism with a selective inverse agonist.
• Apply chemogenetic tools (hM4Di) to suppress GABA release locally in BNST of aged mice, then assess anxiety‑like behavior in elevated plus maze and fear extinction retention.
• Compare the impact of a 5‑HT2C antagonist (SB‑242084) on anxiety scores in young versus aged cohorts.

If predictions hold, this work would integrate structural aging data with molecular CRF circuit mechanisms, offering a novel explanation for why anxiety often wanes with age and identifying GABAergic modulation of BNST CRF neurons as a potential therapeutic target for anxiety disorders.